Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: A prospective study

Lancet

Volumn 358, Issue 9276, 2001, Pages 115-119

  Humphries, Steve E ^a   Talmud, Philippa J ^a   Hawe, Emma ^a   Bolla, Manjeet ^a   Day, Ian N M ^a,c   Miller, George J ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; LIPID;

ADULT; ALLELE; ANALYTIC METHOD; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY SURGERY; DISEASE CARRIER; FOLLOW UP; GENOTYPE; HEART INFARCTION; HOMOZYGOSITY; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SMOKING; SMOKING HABIT;

EID: 0035859488     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)05330-2     Document Type: Article

References (36)

1. Mortality of British doctors in relation to smoking; observation on coronary thrombosis
2. The effect of cigarette smoke, nicotine, and carbon monoxide on the permeability of the arterial wall
3. The acute influence of smoking on the endothelium
4. Blood viscosity and cardiovascular risk
5. The insulin resistance syndrome and postprandial lipid intolerance in smokers
6. The human beta fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element
7. Increased levels of autoantibodies to cardiolipin and oxidised low density lipoprotein are inversely associated with plasma vitamin C status in cigarette smokers
8. Apolipoprotein E polymorphism and atherosclerosis
9. Apolipoprotein E alleles and risk of coronary disease: A meta-analysis
10. The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease
11. The apolipoprotein epsilon4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction: A substudy of the Scandinavian simvastatin survival study
12. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
13. Apolipoprotein E polymorphism and Alzheimer's disease
14. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: The Rotterdam study
15. Smoking and dementia in male British doctors: Prospective study
16. The effects of quality and timing of venepuncture on markers of blood coagulation in healthy middle-aged men
17. Substitution of asparagine for aspartic acid at residue 9 (D9N) of lipoprotein lipase markedly augments risk of coronary heart disease in male smokers
18. Utility of the predictors of coronary heart disease mortality in a longitudinal study of elderly Finnish men aged 65-84 years is dependent on context defined by Apo E genotype and area of residence
19. Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease
20. A simple salting out procedure for extracting DNA from human nucleated cells
21. High-throughput method for determination of apolipoprotein E genotypes with use of restriction digestion analysis by microplate array diagonal gel electrophoresis
22. Electrophoresis for genotyping: Microtiter array diagonal gel electrophoresis on horizontal polyacrylamide gels, hydrolink, or agarose
23. Lipoprotein (a) as a predictor for myocardial infarction in the Second Northwick Park Heart Study: A prospective study in middle-aged men
24. Blood pressure in smokers and nonsmokers: Epidemiologic findings
25. Apolipoprotein E polymorphisms affect atherosclerosis in young males
26. Apolipoprotein E polymorphism is associated with segment-specific extracranial carotid artery intima-media thickening
27. The relationship between apolipoprotein E and serum oxidation-related variables is apolipoprotein E phenotype dependent
28. Apolipoprotein E polymorphism and LDL size in a biethnic population: Multilocus genetic determinants of LDL particle size in coronary artery disease families
29. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B
30. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum
31. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice
32. Complete atherosclerosis regression after human apoE gene transfer in apoE deficient/nude mice
33. Apolipoprotein E inhibition of vascular smooth muscle cell proliferation but not the inhibition of migration is mediated through activation of inducible nitric oxide synthase